Professor Jamie Coleman MBChB, MD, MA (Med Ed), FRCP, FBPharmacolS, FFPM(Hons)

Professor Jamie Coleman

Birmingham Medical School
Professor of Clinical Pharmacology and Medical Education, Programme Lead Education for Health Professionals

Contact details

Institute of Clinical Sciences
College of Medical and Dental Sciences
University of Birmingham
B15 2TT

Jamie Coleman is currently an Honorary Professor in Clinical Pharmacology and Medical Education and works part time for the University in his role as Programme Lead for Education for Health Professionals Masters courses.

Previously a full time clinical academic, Jamie has been deputy lead for the Medical degree Course at Birmingham and led the Physicians Associate programme for a number of years. He now works as Consultant Physician and Associate Medical Director at University Hospitals Birmingham NHS Foundation Trust, but continues a wide range of teaching and research activities within the University. 


  • Honorary Professor of Clinical Pharmacology and Medical Education
  • Honorary Fellow of the Faculty of Pharmaceutical Medicine (2018)
  • Fellow of the British Pharmacological Society (2014)
  • Fellow of the Royal College of Physicians (2014)
  • MA (Medical Education), University of Bedfordshire (2008)
  • MD, University of Birmingham (2008)
  • Postgraduate Certificate in Higher Education Leadership (2007)
  • Postgraduate Certificate in Medical Education (2004)
  • Membership of Royal College of Physicians (2002)
  • MBChB, University of Birmingham (1999)


Jamie Coleman is Honorary Professor of Clinical Pharmacology and Medical Education within the School of Medicine in the Institute of Clinical Sciences. He was previously the Deputy Programme Director of the MBChB programme, and continues as the Therapeutics Lead for the BDS Dentistry course, and co-lead for Pharmacogenomics and Stratified Healthcare within the MSc Genomic Medicine Programme.

His main academic responsibilities are as the programme lead for the Postgraduate Masters suite of courses in Education for Health Professionals within the College of Medical and Dental Sciences.

He has a long standing interest in undergraduate and postgraduate healthcare education and has authored a number of highly cited pedagogical research papers and systematic reviews. He maintains a strong interest in educational research and works with colleagues in the School of Medicine and the School of Education in the University on several projects in undergraduate medical education and inter-professional learning. Much of his research interests revolve around elements of prescribing safety and the analysis of routinely collected prescription data from both primary and secondary care.

Jamie has also been instrumental in the establishment of SCRIPT, a suite of e-learning modules to develop and maintain professional knowledge and competence in prescribing and therapeutics. He is also an active clinician working in General Internal Medicine looking after a 36 bedded ward at the Queen Elizabeth Hospital and a large outpatient service looking after non-specific cancer symptoms. He is associate medical director at University Hospitals Birmingham responsible for Medicines Management across four hospital sites.


Postgraduate supervision

Jamie has supervised 3 PhD students and one MD student to completion, and currently has one PhD student co-supervised with the School of Pharmacy. He has also supported two students with EdD (Educational Doctorates) with the School of Education.


Jamie has conducted research into adverse drug reactions, medication errors, and other aspects of clinical pharmacology. Work has included being local co-investigator for a large multi-national, multi-centre trial in Hypertension. Much of his current work is on the epidemiology of adverse drug reactions and electronic prescribing. His Doctor of Medicine (MD) research has given him wide ranging experience in systematic reviews, quantitative analysis of large datasets, and data management.

Having been the principal investigator on a 5 year programme of research investigating Patient Safety and Information Technology, he has also been co-PI with Professor Sir Aziz Sheikh on two NIHR funded Programme Grants for Applied Health Research investigating various aspects of electronic prescribing.

Other activities

Jamie is the training programme director in the West Midlands for Clinical Pharmacology and therapeutics, and for General Internal Medicine Standalone training – supporting the education and training of Postgraduate Doctors in Training at Specialist Registrar level.

He chairs the Specialist Advisory Committee nationally in Clinical Pharmacology and Therapeutics.

Jamie works closely with the Medicines and Healthcare Products Regulatory Agency and chairs the Pharmacovigilance Expert Advisory Group nationally. He is a member of the Commission of Human Medicines – the licensing body for medicines in the UK and sits on the Expert working groups for Cancer Vaccines and Non-Medical Prescribing.

As previous chairperson for the European Association for Clinical Pharmacology and Therapeutics, he remains an active member of the EACPT working group in Education. He also supports the work of the education sub-committee and clinical division of the International Union of Basic and Clinical Pharmacology.


Selected publications:

  • Dixon-Woods M, Redwood S, Leslie M, Minion J, Martin GP, Coleman JJ. (2013) Improving quality and safety of care using "technovigilance": an ethnographic case study of secondary use of data from an electronic prescribing and decision support system. Milbank Q.; 91(3):424-54.
  • Nirantharakumar K, Hemming K, Narendran P, Marshall T, Coleman JJ. (2013) A Prediction Model for Adverse Outcome in Hospitalized Patients With Diabetes. Diabetes Care; 36: 3566-3572.
  • Coleman JJ, Hodson J, Thomas SK, Brooks HL, Ferner RE. (2015) Temporal and other factors that influence the time doctors take to prescribe using an electronic prescribing system. J Am Med Inform Assoc; 22(1):206-12.
  • Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview. King A, Cresswell KM, Coleman JJ, Pontefract SK, Slee A, Williams R, Sheikh A. J R Soc Med. 2017 Aug;110(8):320-329.
  • Pontefract SK, Hodson J, Slee A, Shah S, Girling AJ, Williams R, Sheikh A, Coleman JJ. (2018). Impact of a commercial order entry system on prescribing errors amenable to computerised decision support in the hospital setting: a prospective pre-post study. BMJ Qual Saf. bmjqs-2017-007135. doi: 10.1136/bmjqs-2017-007135.
  • Pontefract SK, Coleman JJ, Vallance HK, Hirsch CA, Shah S, Marriott JF, Redwood S. (2018). The impact of computerised physician order entry and clinical decision support on pharmacist-physician communication in the hospital setting: A qualitative study. PLoS One;13(11):e0207450.
  • Coleman JJ. (2019) Prescribing in 2019: what are the safety concerns? Expert Opin Drug Saf.;18(2):69-74.
  • Coleman JJ, Samer C, Zeitlinger M, van Agtmael M, Rongen GA, Marquet P, Simon T, Singer D, Manolopoulos VG, Böttiger Y. (2019). The European Association for Clinical Pharmacology and Therapeutics-25 years' young and going strong. Eur J Clin Pharmacol. ;75(6):743-750

Richards D, Coleman JJ, Reynolds J, Aronson JK. Oxford Handbook of Practical Drug Therapy (2nd Ed). Oxford University Press; Oxford, 2011.

View all publications in research portal